Bartoszyk GD - Search Results

1

Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity.

Heinrich T, Böttcher H, Schiemann K, Hölzemann G, Schwarz M, Bartoszyk GD, van Amsterdam C, Greiner HE, Seyfried CA. Heinrich T, et al. Among authors: bartoszyk gd. Bioorg Med Chem. 2004 Sep 15;12(18):4843-52. doi: 10.1016/j.bmc.2004.07.014. Bioorg Med Chem. 2004. PMID: 15336263

2

Indolebutylamines as selective 5-HT(1A) agonists.

Heinrich T, Böttcher H, Bartoszyk GD, Greiner HE, Seyfried CA, Van Amsterdam C. Heinrich T, et al. Among authors: bartoszyk gd. J Med Chem. 2004 Sep 9;47(19):4677-83. doi: 10.1021/jm040792y. J Med Chem. 2004. PMID: 15341483

3

Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors.

Heinrich T, Böttcher H, Gericke R, Bartoszyk GD, Anzali S, Seyfried CA, Greiner HE, Van Amsterdam C. Heinrich T, et al. Among authors: bartoszyk gd. J Med Chem. 2004 Sep 9;47(19):4684-92. doi: 10.1021/jm040793q. J Med Chem. 2004. PMID: 15341484

4

SAR of novel biarylmethylamine dopamine D4 receptor ligands.

Arlt M, Böttcher H, Riethmüller A, Schneider G, Bartoszyk GD, Greiner H, Seyfried CA. Arlt M, et al. Among authors: bartoszyk gd. Bioorg Med Chem Lett. 1998 Aug 4;8(15):2033-8. doi: 10.1016/s0960-894x(98)00361-8. Bioorg Med Chem Lett. 1998. PMID: 9873481

5

EMD 281014, a new selective serotonin 5-HT2A receptor antagonist.

Bartoszyk GD, van Amsterdam C, Böttcher H, Seyfried CA. Bartoszyk GD, et al. Eur J Pharmacol. 2003 Jul 25;473(2-3):229-30. doi: 10.1016/s0014-2999(03)01992-7. Eur J Pharmacol. 2003. PMID: 12892843

6

Synthesis and in vitro and in vivo functional studies of ortho-substituted phenylpiperazine and N-substituted 4-N-(o-methoxyphenyl)aminopiperidine analogues of WAY100635.

Mensonides-Harsema MM, Liao Y, Böttcher H, Bartoszyk GD, Greiner HE, Harting J, de Boer P, Wikström HV. Mensonides-Harsema MM, et al. Among authors: bartoszyk gd. J Med Chem. 2000 Feb 10;43(3):432-9. doi: 10.1021/jm991088y. J Med Chem. 2000. PMID: 10669570

7

Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile.

Bartoszyk GD, Van Amsterdam C, Greiner HE, Rautenberg W, Russ H, Seyfried CA. Bartoszyk GD, et al. J Neural Transm (Vienna). 2004 Feb;111(2):113-26. doi: 10.1007/s00702-003-0094-7. Epub 2003 Dec 31. J Neural Transm (Vienna). 2004. PMID: 14767715

8

The peripherally acting kappa-opiate agonist EMD 61753 and analogues: opioid activity versus peripheral selectivity.

Gottschlich R, Barber A, Bartoszyk GD, Seyfried CA. Gottschlich R, et al. Among authors: bartoszyk gd. Drugs Exp Clin Res. 1995;21(5):171-4. Drugs Exp Clin Res. 1995. PMID: 8846746

9

Sensitivity of dopamine D2 receptors following long-term treatment with roxindole.

Seyfried CA, Bartoszyk GD. Seyfried CA, et al. Among authors: bartoszyk gd. Eur J Pharmacol. 1994 May 12;257(1-2):67-72. doi: 10.1016/0014-2999(94)90695-5. Eur J Pharmacol. 1994. PMID: 7915991

10

Electrophysiological evidence for rapid 5-HT₁A autoreceptor inhibition by vilazodone, a 5-HT₁A receptor partial agonist and 5-HT reuptake inhibitor.

Ashby CR Jr, Kehne JH, Bartoszyk GD, Renda MJ, Athanasiou M, Pierz KA, Seyfried CA. Ashby CR Jr, et al. Among authors: bartoszyk gd. Eur J Pharmacol. 2013 Aug 15;714(1-3):359-65. doi: 10.1016/j.ejphar.2013.07.014. Epub 2013 Jul 16. Eur J Pharmacol. 2013. PMID: 23872377 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters